PlainRecalls
FDA Drug Moderate Class II Terminated

Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytotoxic Agent, Manufactured by: Shilpa Medicare Limited, Jadcherla, 509301, India, Distributed by: Armas Pharmaceuticals, Inc. Manalapan, NJ 07726 NDC 72485-201-01.

Reported: December 16, 2020 Initiated: December 8, 2020 #D-0122-2021

Product Description

Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytotoxic Agent, Manufactured by: Shilpa Medicare Limited, Jadcherla, 509301, India, Distributed by: Armas Pharmaceuticals, Inc. Manalapan, NJ 07726 NDC 72485-201-01.

Reason for Recall

CGMP Deviations

Details

Recalling Firm
Shilpa Medicare Limited
Units Affected
35,931 vials
Distribution
Nationwide in the U.S.
Location
Polepally, Jadcherla, N/A

Frequently Asked Questions

What product was recalled?
Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytotoxic Agent, Manufactured by: Shilpa Medicare Limited, Jadcherla, 509301, India, Distributed by: Armas Pharmaceuticals, Inc. Manalapan, NJ 07726 NDC 72485-201-01.. Recalled by Shilpa Medicare Limited. Units affected: 35,931 vials.
Why was this product recalled?
CGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on December 16, 2020. Severity: Moderate. Recall number: D-0122-2021.